SCHEMBL28457041

SCHEMBL28457041

CC(C)C(NC(=O)OC(C)(C)C)c1nc2cc(-c3ccnc(Cl)c3)sc2c(=O)[nH]1

nearest known ligand 0.42

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ AAK1 Q2M2I8 7/20 0.42
▸ CDC7 O00311 3/20 0.41
▸ DBF4 Q9UBU7 3/20 0.41
▸ RAB9A P51151 3/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ PKM P14618 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ ABCB1 P08183 5/20 0.36
▸ TRPA1 O75762 1/20 0.35
▸ ROCK1 Q13464 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21729493 1.00 AAK1 (0.42) AAK1CDC7DBF4RAB9AKDM4E
SCHEMBL28453787 0.91 CDC7 (0.43) AAK1CDC7DBF4RAB9AKDM4E
SCHEMBL21729495 0.91 CDC7 (0.43) AAK1CDC7DBF4RAB9AKDM4E
SCHEMBL21729500 0.89 AAK1 (0.42) AAK1CDC7DBF4RAB9AKDM4E
SCHEMBL21712591 0.89 CDC7 (0.46) CDC7DBF4RAB9AKDM4ELMNA
SCHEMBL21729586 0.86 AAK1 (0.39) AAK1CDC7DBF4RAB9AKDM4E
SCHEMBL21729557 0.84 AAK1 (0.41) AAK1CDC7DBF4RAB9AMEN1
SCHEMBL28455399 0.84 AAK1 (0.41) AAK1CDC7DBF4RAB9AMEN1
SCHEMBL21729515 0.84 AAK1 (0.37) AAK1CDC7DBF4RAB9AKDM4E
SCHEMBL28458939 0.84 AAK1 (0.37) AAK1CDC7DBF4RAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112409373-A Substituted [5,6] cyclo-4 (3H) -pyrimidinones as anticancer agents 南京正济医药研究有限公司 2021-02-26 — — CN disclosed
CN-110381950-B Substituted [5,6] cyclo-4 (3H) -pyrimidinones as anticancer agents 南京正济医药研究有限公司 2020-09-04 — — CN disclosed
Send feedback